Abstract Library

#2813 Clinical Presentation and Prognosis of Patients with Medullary Thyroid Cancer

Introduction: Medullary thyroid carcinoma (MTC) is a rare type of tumor that originates from parafollicular C-cells and accounts for 3–4% of all malignant thyroid neoplasms. MTC presents as sporadic (75–80%) or inherited tumors (20–25%). Hereditary MTC is part of multiple endocrine neoplasia type 2 (MEN2).

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: de Cicco F, Modica R, Barba L, Bottiglieri F, Minotta R,

Keywords: Medullary thyroid carcinoma, natural history, treatment, prognosis,

#2043 Combination of Surgery and Ethanol Ablation in a MEN-2A Patient

Introduction: MEN-2A is an autosomal dominant syndrome characterized by pheochromocytoma, medullary thyroid carcinoma and hyperparathyroidism.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Fang Z

Authors: Fang Z, Tan H, Wang Y, Cai X, Luo J,

Keywords: Men-2a, pheochromocytoma, ethanol ablation,

#462 Genome-Wide Expression Profiling Reveals Downregulation of OTP and CD44 and Upregulation of RET as Indicators of Poor Prognosis in Lung Carcinoids

Introduction: Lung carcinoids comprise a heterogeneous group of neuroendocrine tumors. Only few parameters have been identified that correlated with poor disease outcome, including 11q22-q25 deletions. New biomarkers are required to further improve diagnosis and prediction of prognosis.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Swarts D, Van Neste L, Henfling M, Van Suylen R, Volante M,

Keywords: Bronchial carcinoids, cDNA microarray, MEN-2,